Eugene Kinyanda1,2,3, Jonathan Levin4, Noeline Nakasujja2, Harriet Birabwa5, Juliet Nakku5, Richard Mpango1, Heiner Grosskurth3, Soraya Seedat6, Ricardo Araya7, Maryam Shahmanesh8, Vikram Patel9. 1. Mental Health Project, MRC/UVRI Uganda Research Unit on AIDS/Senior Wellcome Trust Fellowship, Entebbe, Uganda. 2. Department of Psychiatry, Makerere College of Health Sciences, Kampala, Uganda. 3. Department of Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. 4. School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 5. Butabika National Psychiatric Referral Hospital, Kampala, Uganda. 6. Department of Psychiatry, Stellenbousch University, Cape Town, South Africa. 7. Health Service and Population Research, Centre for Global Mental Health and Primary Care Research, King's College, London, United Kingdom. 8. Central and North West London NHS Foundation Trust, London, United Kingdom. 9. Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA.
Abstract
BACKGROUND: There is still wide variability in HIV disease course and other HIV-related outcomes, attributable in part to psychosocial factors such as major depressive disorder (MDD), a subject that has received little attention in sub-Saharan Africa. METHODS: Using a longitudinal cohort of 1099 HIV-positive antiretroviral therapy-naive persons, we investigated the impact of MDD on 4 HIV-related negative outcome domains in Uganda. MDD was assessed using a Diagnostic Statistical Manual IV-based tool. Also collected were data on surrogate measures of the HIV-related outcome domains. Data were collected at the 3 time points of baseline, 6, and 12 months. Multiple regression and discrete time survival models were used to investigate the relationship between MDD and indices of the HIV outcomes. RESULTS: MDD was a significant predictor of "missed antiretroviral therapy doses" [adjusted odds ratio (aOR) = 4.75, 95% confidence interval (CI): 1.87 to 12.04, P = 0.001], "time to first visit to healthy facility" (aOR = 1.71; 95% CI: 1.07 to 2.73; P = 0.024), "time to first self-reported risky sexual activity" (aOR = 2.11, 95% CI: 1.27 to 3.49; P = 0.004) but not of "CD4 counts at months 6 and 12" (estimated effect 29.0; 95% CI: -7.8 to 65.7; P = 0.12), and "time to new WHO stage 3 or 4 clinical event" (aOR = 0.52, 95% CI: 0.12 to 2.20, P = 0.37). CONCLUSIONS: MDD significantly impacted 3 of the 4 investigated outcome domains. These results by demonstrating the adverse consequences of an untreated mental health disorder (MDD) on HIV-related outcomes further strengthen the need to urgently act on WHO's call to integrate mental health care in general HIV care.
BACKGROUND: There is still wide variability in HIV disease course and other HIV-related outcomes, attributable in part to psychosocial factors such as major depressive disorder (MDD), a subject that has received little attention in sub-Saharan Africa. METHODS: Using a longitudinal cohort of 1099 HIV-positive antiretroviral therapy-naive persons, we investigated the impact of MDD on 4 HIV-related negative outcome domains in Uganda. MDD was assessed using a Diagnostic Statistical Manual IV-based tool. Also collected were data on surrogate measures of the HIV-related outcome domains. Data were collected at the 3 time points of baseline, 6, and 12 months. Multiple regression and discrete time survival models were used to investigate the relationship between MDD and indices of the HIV outcomes. RESULTS: MDD was a significant predictor of "missed antiretroviral therapy doses" [adjusted odds ratio (aOR) = 4.75, 95% confidence interval (CI): 1.87 to 12.04, P = 0.001], "time to first visit to healthy facility" (aOR = 1.71; 95% CI: 1.07 to 2.73; P = 0.024), "time to first self-reported risky sexual activity" (aOR = 2.11, 95% CI: 1.27 to 3.49; P = 0.004) but not of "CD4 counts at months 6 and 12" (estimated effect 29.0; 95% CI: -7.8 to 65.7; P = 0.12), and "time to new WHO stage 3 or 4 clinical event" (aOR = 0.52, 95% CI: 0.12 to 2.20, P = 0.37). CONCLUSIONS: MDD significantly impacted 3 of the 4 investigated outcome domains. These results by demonstrating the adverse consequences of an untreated mental health disorder (MDD) on HIV-related outcomes further strengthen the need to urgently act on WHO's call to integrate mental health care in general HIV care.
Authors: Amanda P Miller; Cristina Espinosa da Silva; Leo Ziegel; Stephen Mugamba; Emma Kyasanku; Robert B Malyabe; Jennifer A Wagman; Anna Mia Ekström; Fred Nalugoda; Grace Kigozi; Gertrude Nakigozi; Josehp Kagaayi; Stephen Watya; Godfrey Kigozi Journal: Psychiatry Res Commun Date: 2021-10-30
Authors: Ingrid V Bassett; Ai Xu; Janet Giddy; Laura M Bogart; Andrew Boulle; Lucia Millham; Elena Losina; Robert A Parker Journal: AIDS Care Date: 2020-11-02
Authors: Eugene Kinyanda; Leticia Kyohangirwe; Richard S Mpango; Christine Tusiime; Joshua Ssebunnya; Kenneth Katumba; Patrick Tenywa; James Mugisha; Geoffrey Taasi; Hafsa Sentongo; Dickens Akena; Yoko Laurence; Wilson Muhwezi; Helen A Weiss; Melissa Neuman; Giulia Greco; Birthe Knizek; Jonathan Levin; Pontiano Kaleebu; Ricardo Araya; Wilber Ssembajjwe; Vikram Patel Journal: Int J Ment Health Syst Date: 2021-05-12
Authors: Allan Kalungi; Jacqueline S Womersley; Eugene Kinyanda; Moses L Joloba; Wilber Ssembajjwe; Rebecca N Nsubuga; Soraya Seedat; Sian M J Hemmings Journal: Front Genet Date: 2021-04-23 Impact factor: 4.599
Authors: Jon C Mills; Brian W Pence; Andrew Edmonds; Adebola Adedimeji; Rebecca M Schwartz; Seble Kassaye; Jennifer Cocohoba; Mardge H Cohen; Gretchen Neigh; Margaret A Fischl; Mirjam-Colette Kempf; Adaora A Adimora Journal: J Acquir Immune Defic Syndr Date: 2019-11-01 Impact factor: 3.771
Authors: Allan Kalungi; Eugene Kinyanda; Jacqueline S Womersley; Moses L Joloba; Wilber Ssembajjwe; Rebecca N Nsubuga; Pontiano Kaleebu; Jonathan Levin; Martin Kidd; Soraya Seedat; Sian M J Hemmings Journal: BMC Med Genomics Date: 2021-01-06 Impact factor: 3.063